AAC Holdings, Inc. provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention. As of December 31, 2018, the company operated 11 inpatient substance abuse treatment facilities, focused on delivering clinical care and treatment solutions across 1,080 inpatient beds, including 700 licensed detoxification beds, 24 standalone outpatient centers, and 4 sober living facilities across 471 beds for a total of 1,551 combined inpatient and sober living beds. It also offers multi-media marketing services to families and individuals struggling with addiction and seeking treatment options through online directories of treatment providers, treatment provider reviews, forums, and professional communities. In addition, the company performs drug testing and diagnostic laboratory services; and provides physician services to its clients. AAC Holdings, Inc. was founded in 2014 and is headquartered in Brentwood, Tennessee.
Industry, Sector and Symbol
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Phone615-732-1231
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$295.76 million
Profitability
Miscellaneous
Employees1,900
Next Earnings Date8/7/2019 (Estimated)
OptionableOptionable
AAC (NYSE:AAC) Frequently Asked Questions
What is AAC's stock symbol?
AAC trades on the New York Stock Exchange (NYSE) under the ticker symbol "AAC."
How were AAC's earnings last quarter?
AAC Holdings Inc (NYSE:AAC) released its quarterly earnings data on Thursday, May, 9th. The company reported ($0.79) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.13) by $0.66. The firm earned $55.37 million during the quarter, compared to analysts' expectations of $75.16 million. AAC had a negative net margin of 26.42% and a negative return on equity of 49.55%. View AAC's Earnings History.
When is AAC's next earnings date?
What guidance has AAC issued on next quarter's earnings?
AAC issued an update on its FY 2019 earnings guidance on Tuesday, April, 16th. The company provided earnings per share (EPS) guidance of $-0.3--0.2 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.08. The company issued revenue guidance of $290-310 million, compared to the consensus revenue estimate of $312.25 million.
What price target have analysts set for AAC?
2 brokerages have issued 12-month price objectives for AAC's shares. Their forecasts range from $4.00 to $5.00. On average, they expect AAC's stock price to reach $4.50 in the next year. This suggests a possible upside of 287.9% from the stock's current price. View Analyst Price Targets for AAC.
What is the consensus analysts' recommendation for AAC?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AAC in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AAC.
Has AAC been receiving favorable news coverage?
Media coverage about AAC stock has been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. AAC earned a daily sentiment score of -1.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future.
Who are some of AAC's key competitors?
Some companies that are related to AAC include Provention Bio (PRVB), Foamix Pharmaceuticals (FOMX), Novavax (NVAX), Galmed Pharmaceuticals (GLMD), Neon Therapeutics (NTGN), Sesen Bio (SESN), Harvest One Cannabis (HVT), Paratek Pharmaceuticals (PRTK), Matinas BioPharma (MTNB), Eton Pharmaceuticals (ETON), ADOCIA/S (ADOCY), Hamilton Thorne (HTL), Stereotaxis (STXS), Tristel (TSTL) and Equillium (EQ).
What other stocks do shareholders of AAC own?
Who are AAC's key executives?
AAC's management team includes the folowing people:
- Mr. Michael T. Cartwright, Chairman & CEO (Age 51)
- Mr. Michael Nanko Ph.D., Pres & COO (Age 63)
- Dr. Thomas W. Doub, Chief Compliance Officer & Chief Clinical Officer (Age 50)
- Mr. Andrew W. McWilliams, Chief Financial Officer (Age 47)
- Mr. Michael J. Stetar, Chief Technology Officer
Who are AAC's major shareholders?
AAC's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Royce & Associates LP (7.36%), TimesSquare Capital Management LLC (7.30%), BlackRock Inc. (3.06%), Morgan Stanley (2.51%), Apollo Management Holdings L.P. (1.21%) and Spark Investment Management LLC (0.10%). Company insiders that own AAC stock include Darrell S Freeman, David C Kloeppel, Jerrod N Menz, Michael J Blackburn, Michael Nanko, Michael T Cartwright and W Larry Cash. View Institutional Ownership Trends for AAC.
Which major investors are selling AAC stock?
AAC stock was sold by a variety of institutional investors in the last quarter, including Apollo Management Holdings L.P., Morgan Stanley, TimesSquare Capital Management LLC, BlackRock Inc. and Spark Investment Management LLC. View Insider Buying and Selling for AAC.
Which major investors are buying AAC stock?
AAC stock was acquired by a variety of institutional investors in the last quarter, including Royce & Associates LP. Company insiders that have bought AAC stock in the last two years include Darrell S Freeman, Michael Nanko and W Larry Cash. View Insider Buying and Selling for AAC.
How do I buy shares of AAC?
Shares of AAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is AAC's stock price today?
One share of AAC stock can currently be purchased for approximately $1.16.
How big of a company is AAC?
AAC has a market capitalization of $29.35 million and generates $295.76 million in revenue each year. The company earns $-59,400,000.00 in net income (profit) each year or ($1.06) on an earnings per share basis. AAC employs 1,900 workers across the globe.
What is AAC's official website?
How can I contact AAC?
AAC's mailing address is 200 POWELL PLACE, BRENTWOOD TN, 37027. The company can be reached via phone at 615-732-1231 or via email at [email protected]
MarketBeat Community Rating for AAC (NYSE AAC)
MarketBeat's community ratings are surveys of what our community members think about AAC and other stocks. Vote "Outperform" if you believe AAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AAC will underperform the S&P 500 over the long term. You may vote once every thirty days.
